Risk of Serious Infection in Patients With Rheumatoid Arthritis Treated With Biologic Versus Nonbiologic Disease‐Modifying Antirheumatic Drugs-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Risk of Serious Infection in Patients With Rheumatoid Arthritis Treated With Biologic Versus Nonbiologic Disease‐Modifying Antirheumatic Drugs

Published:2019-08-06 Issue:7 Volume:1 Page:424-432
ISSN:2578-5745
Container-title:ACR Open Rheumatology
language:en
Short-container-title:ACR Open Rheuma

Author:

Ozen Gulsen¹^ORCID,Pedro Sofia²,England Bryant R.³^ORCID,Mehta Bella⁴,Wolfe Frederick²^ORCID,Michaud Kaleb⁵^ORCID

Affiliation:

1. University of Nebraska Medical Center Omaha

2. FORWARD–The National Databank for Rheumatic Diseases Wichita Kansas

3. University of Nebraska Medical Center and VA Nebraska‐Western Iowa Health Care System Omaha

4. Hospital for Special Surgery New York New York

5. University of Nebraska Medical Center, Omaha, and FORWARD–The National Databank for Rheumatic Diseases Wichita Kansas

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/acr2.11064

Reference45 articles.

1. Frequency of infection in patients with rheumatoid arthritis compared with controls: A population-based study

2. Anti-TNF therapy is associated with an increased risk of serious infections in patients with rheumatoid arthritis especially in the first 6 months of treatment: updated results from the British Society for Rheumatology Biologics Register with special emphasis on risks in the elderly

3. Cause-specific mortality in patients with psoriatic arthritis and rheumatoid arthritis

4. The risk of infections associated with rheumatoid arthritis, with its comorbidity and treatment

5. Improvement in 5-year mortality in incident rheumatoid arthritis compared with the general population—closing the mortality gap

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A narrative review of the comparative safety of disease-modifying anti-rheumatic drugs used for the treatment of rheumatoid arthritis;Expert Opinion on Drug Safety;2024-05-23

2. DAP1-2: a synthetic peptide targeting IL-1R1 receptor effectively suppresses IL-1β in vitro;Immunologic Research;2024-05-02

3. Actualización de las Guías para el Tratamiento Farmacológico de la Artritis Reumatoide del Colegio Mexicano de Reumatología 2023;Reumatología Clínica;2024-05

4. Update of the guidelines for the pharmacological treatment of rheumatoid arthritis by the Mexican College of Rheumatology 2023;Reumatología Clínica (English Edition);2024-05

5. Predictors of serious infections in rheumatoid arthritis—a prospective Brazilian cohort;Advances in Rheumatology;2024-03-29

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3